Apyx Medical Plans First Quarter 2025 Financial Update Release
Upcoming Release of Financial Results for 2025
At Apyx Medical Corporation (NASDAQ: APYX), located in Clearwater, Florida, an important event is on the horizon. The company, renowned for its innovative helium plasma and radiofrequency technology branded as Renuvion, has stated that it will announce its financial performance for the first quarter of fiscal year 2025. This release is scheduled to occur before the markets open on Thursday, May 8th.
Details of the Conference Call
Management at Apyx Medical is keen to engage with investors and analysts during a conference call aimed at discussing the quarterly results. Scheduled for 8:00 a.m. Eastern Time on the same day, this call will offer insights into the company's performance and strategic direction moving forward. Participants wishing to attend may join by dialing 800-717-1738 or 646-307-1865 internationally, ensuring they have the access code 63341 at hand. This session will allow for a comprehensive review along with a question-and-answer segment to enhance dialogue between the company and its stakeholders.
Accessing the Live Webcast
For those who prefer to engage via online platforms, Apyx Medical will also provide a live webcast of the call. This can be accessed via their official website where it will be archived for future reference. This webcast will allow those interested to follow along and gain insights into the company’s updates post-announcement.
Connecting with Investor Relations
For detailed inquiries regarding Apyx Medical’s fiscal updates, Jeremy Feffer, Managing Director at LifeSci Advisors, is available for contact. Investors can reach out directly at 212-915-2568 or via email for personalized communication. This level of accessibility showcases Apyx Medical's commitment to transparency and effective communication with its shareholders.
About Apyx Medical Corporation
Apyx Medical Corporation stands at the forefront of advanced energy technology, driven by a mission to improve the lives of individuals through its remarkable products. The company’s Helium Plasma Platform Technology, marketed under the Renuvion and J-Plasma brands, represents the pinnacle of innovation in cosmetic and surgical medicine. These products equip surgeons with the capability to apply controlled heat to tissue, enabling precise and desired outcomes. A wealth of over 90 clinical publications underpins the efficacy of Renuvion and J-Plasma, reinforcing Apyx Medical's reputation as a trusted leader in the field.
Broadening Horizons Through OEM Agreements
Apyx Medical's extensive expertise in creating unique waveforms also translates into fruitful collaborations. Through original equipment manufacturer (OEM) agreements with other medical device firms, Apyx leverages its technological prowess to enhance various medical offerings across the landscape. This innovative spirit keeps the company ahead in delivering solutions that cater to the evolving needs of healthcare professionals.
Further Information and Resources
Individuals looking to explore more about the company's offerings or financial updates can visit the official Apyx Medical website. Their online presence serves as a hub for vital resources, including product information and upcoming events that could shape the trajectory of the company. Apyx Medical's ongoing dedication to expanding its market presence while maintaining exceptional standards in product efficacy remains a cornerstone of its strategy.
Frequently Asked Questions
What is the date for Apyx Medical's financial results release?
The financial results for the first quarter of fiscal year 2025 will be released on May 8, 2025.
How can I participate in the Apyx Medical conference call?
To join the conference call, dial 800-717-1738 or 646-307-1865 for international calls and use access code 63341.
Where can I find the webcast of the conference call?
A live webcast of the conference call will be available on Apyx Medical's official website, along with an archive for later access.
Who should I contact for investor relations inquiries?
Jeremy Feffer, Managing Director at LifeSci Advisors, can be contacted at 212-915-2568 or via email for any investor relations questions.
What technologies does Apyx Medical focus on?
Apyx Medical specializes in advanced energy technologies, particularly helium plasma and radiofrequency technologies like Renuvion and J-Plasma for surgical applications.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.